Origin and impact of multifocal growth in sporadic vs. hereditary medullary thyroid cancer

被引:3
|
作者
Machens, Andreas [1 ]
Lorenz, Kerstin [1 ]
Weber, Frank [2 ]
Dralle, Henning [1 ,2 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Visceral Vasc & Endocrine Surg, Ernst-Grube-Str 40, D-06097 Halle, Germany
[2] Univ Duisburg Essen, Dept Gen Visceral & Transplantat Surg, Div Endocrine Surg, D-45122 Essen, Germany
来源
EJSO | 2024年 / 50卷 / 11期
关键词
Medullary thyroid carcinoma; RET proto-oncogene; Malignant progression; Tumor multifocality; Microscopic lymphatic invasion; Lymph node metastases;
D O I
10.1016/j.ejso.2024.108625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multifocal growth is characteristic of hereditary medullary thyroid cancer (MTC), whereas origin and impact of multifocal growth is enigmatic for sporadic MTC. To address this, 460 RET-negative patients with sporadic MTC, stratified by 1 (93.3 %), 2 (5.7 %) and 3 (1.1 %) thyroid tumor foci, were compared with 219 RET-positive patients with hereditary MTC, stratified by 1 (38.4 %), 2 (45.7 %), 3 (6.4 %), 4 (6.8 %) and >= 5 (2.7 %) thyroid tumor foci. For sporadic MTC, significant associations were identified with bilateral thyroid lobe involvement, microscopic lymphatic invasion, extrathyroid extension, node and distant metastases, number of node metastases, preoperative basal calcitonin level, and decreasing biochemical cure. For hereditary MTC, significant associations were limited to bilateral thyroid lobe involvement, largest thyroid tumor diameter, and preoperative basal calcitonin level. In sporadic MTC, multifocal growth is due to lymphatic invasion with frequent node metastases, whereas in hereditary MTC, it reflects malignant progression from C-cell hyperplasia to cancer.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer
    Pena, Israel
    Clayman, Gary L.
    Grubbs, Elizabeth G.
    Bergeron, Jeffrey M., Jr.
    Waguespack, Steven G.
    Cabanillas, Maria E.
    Dadu, Ramona
    Hu, Mimi I.
    Fellman, Bryan M.
    Li, Yisheng
    Gross, Neil D.
    Lai, Stephen Y.
    Sturgis, Erich M.
    Zafereo, Mark E.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (01): : 79 - 85
  • [42] The role of RET genotypes as modifier loci for sporadic medullary thyroid cancer
    Muzza, M.
    Mian, C.
    Cordella, D.
    Barollo, S.
    Alberti, L.
    Cirello, V.
    Dazzi, D.
    Girelli, M. E.
    Opocher, G.
    Beck-Peccoz, P.
    Persani, L.
    Fugazzola, L.
    HORMONE RESEARCH, 2007, 68 : 34 - 34
  • [43] Mutation Status in Medullary Thyroid Cancer: Are Outcomes Similar to Sporadic Cases?
    Yamashita, T. Szabo
    Rogers, R. T.
    Foster, T.
    Lyden, M.
    Thompson, G.
    Morris, J.
    McKenzie, T.
    Dy, B.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S81 - S81
  • [44] Ectopic Production of Parathyroid Hormone in a Patient with Sporadic Medullary Thyroid Cancer
    Demura, Masashi
    Yoneda, Takashi
    Wang, Fen
    Zen, Yoh
    Karashima, Shigehiro
    Zhu, Aoshuang
    Cheng, Yuan
    Yamagishi, Masakazu
    Takeda, Yoshiyu
    ENDOCRINE JOURNAL, 2010, 57 (02) : 161 - 170
  • [45] Therapieindividualisierung beim sporadischen und hereditären medullären SchilddrüsenkarzinomIndividualization of treatment in sporadic and hereditary medullary thyroid cancer
    Kerstin Lorenz
    Andreas Machens
    Henning Dralle
    Die Chirurgie, 2024, 95 (3) : 186 - 191
  • [46] The Impact of Calcitonin Trends in Medullary Thyroid Cancer
    Yamashita, T. Szabo
    Rogers, R. T.
    Foster, T.
    Lyden, M.
    Thompson, G.
    Morris, J.
    McKenzie, T.
    Dy, B.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S81 - S81
  • [47] Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma
    Matrone, Antonio
    Gambale, Carla
    Prete, Alessandro
    Piaggi, Paolo
    Cappagli, Virginia
    Bottici, Valeria
    Romei, Cristina
    Ciampi, Raffaele
    Torregrossa, Liborio
    De Napoli, Luigi
    Molinaro, Eleonora
    Materazzi, Gabriele
    Basolo, Fulvio
    Elisei, Rossella
    CANCERS, 2021, 13 (01) : 1 - 13
  • [49] A PHASE II STUDY OF VANDETANIB IN METASTATIC HEREDITARY MEDULLARY THYROID CANCER
    Paz-Ares, L.
    Haddad, R.
    Krebs, A. D.
    Vasselli, J.
    Robinson, B.
    ANNALS OF ONCOLOGY, 2008, 19 : 247 - 247
  • [50] Prophylactic Thyroidectomy in RET Carriers at Risk for Hereditary Medullary Thyroid Cancer
    Machens, Andreas
    Dralle, Henning
    THYROID, 2009, 19 (06) : 551 - 554